Daewoong Pharmaceutical’s ‘Anplone SR Tab’ wipes the market only in 3 years
Daewoong Pharmaceutical’s ‘Anplone SR Tab’ has become the leading product in the sarpogrelate release-type drug market in 3 years of its launch.
According to Daewoong Pharmaceutical, Anplone SR Tab was ranked the top in the sarpogrelate release-type drug market as recording KRW 12.2 billion outp...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
